Botulinum Toxin-A therapy in pediatric urology: Indications for the neurogenic and non-neurogenic neurogenic bladder

TheScientificWorldJournal

Volumn 9, Issue , 2009, Pages 1300-1305

  Dyer, Lori Landau ^a   Franco, Israel ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Botulinum Toxin A; External sphincter dyssynergia; Neurogenic bladder; Non neurogenic neurogenic bladder; Overactive bladder; Pediatric urology; Voiding dysfunction

Indexed keywords

BOTULINUM TOXIN A; BOTULINUM TOXIN B;

ASPIRATION PNEUMONIA; AUTONOMIC DYSREFLEXIA; BLADDER CONTRACTION; BLADDER DISEASE; BLADDER SPHINCTER; BLEPHAROSPASM; BOTULISM; CEREBRAL PALSY; CERVICAL DYSTONIA; CONSTIPATION; CYSTALGIA; DYSTONIA; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL DISEASE; HEMIFACIAL SPASM; HUMAN; HYPERHIDROSIS; LOW DRUG DOSE; MIGRAINE; MUSCLE WEAKNESS; MYOFASCIAL PAIN; NEUROGENIC BLADDER; OVERACTIVE BLADDER; POPULATION; RESPIRATORY FAILURE; REVIEW; SENSORY NERVE; SPHINCTER DYSSYNERGY; STRABISMUS; TREATMENT INDICATION; URINE RETENTION; BLADDER; CHILD; DRUG EFFECT; URETHRA;

BOTULINUM TOXIN TYPE A; CHILD; HUMANS; URETHRA; URINARY BLADDER; URINARY BLADDER, NEUROGENIC;

EID: 73949137294     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2009.146     Document Type: Review

References (20)

1. Smith, C.P., Nishiguchi, J., O'Leary, M., Yoshimura, N., and Chancellor, M.B. (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65(1), 37-41.
2. Rackley, R. and Vasavada, S. (2005) Botulinum Toxin Therapy for Pelvic Health Conditions. AUA Update Series Lesson 39. Vol. 24. American Urological Association. pp. 342-347.
3. Verheyden, J. and Blitzer, A. (2002) Other noncosmetic uses of BOTOX. Dis. Mon. 48(5), 357-366.
4. Keshtgar, A.S., Ward, H.C., Sanei, A., and Clayden, G.S. (2007) Botulinum toxin, a new treatment modality for chronic idiopathic constipation in children: long-term follow-up of a double-blind randomized trial. J. Pediatr. Surg. 42(4), 672-680.
5. Smith, C.P. and Chancellor, M.B. (2004) Emerging role of botulinum toxin in the management of voiding dysfunction. J. Urol. 171(6 Pt 1), 2128-2137.
6. Ruffion, A., Capelle, O., Paparel, P., Leriche, B., Leriche, A., and Grise, P. (2006) What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? BJU Int. 97(5), 1030-1034.
7. Steinhardt, G.F., Naseer, S., and Cruz, O.A. (1997) Botulinum toxin: for dramatic urethral dilatation associated with dysfunctional voiding. J. Urol. 158(1), 190-191.
8. Crowner, B.E., Brunstrom, J.E., and Racete, B.A. (2007) Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient. Clin. Neuropharmacol. 30(5), 310-313.
9. Partikian, A. and Mitchell, W.G. (2007) Iatrogenic botulism in a child with spastic quadriparesis. J. Child Neurol. 22(10), 1235-1237.
10. Hoebeke, P., De Caestecker, K., Vande Walle, J., Dehoorne, J., Raes, A., Verleyen, P., and Van Laecke, E. (2006) The effect of botulinim-A toxin in incontinent children with therapy resistant overactive detrusor. J. Urol. 176(1), 328-331.
11. Radojicic, Z.I., Perovic, S.V., and Milic, N.M. (2006) Is it reasonable to treat refractory voiding dysfunction in children with botulinum-A toxin? J. Urol. 176(1), 332-336.
12. Franco, I., Landau-Dyer, L., Isom-Batz, G., Collett, T., and Reda, E.F. (2007) The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children. J. Urol. 178(4 Pt 2), 1775-1779.
13. Akbar, M., Abelt, R., Seyler, T.M., Bedke, J., Haferkamp, A., Gerner, H.J., and Mohring, K. (2007) Repeated botulinim toxin-A injection in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction. BJU Int. 100(3), 639-645.
14. Riccabona, M., Koen, M., Schindler, M., Goedele, B., Pycha, A., Lusuardi, L., and Bauer, S.B. (2004) Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J. Urol. 171(2 Pt 1), 845-848.
15. Petronijevic, V., Lazovic, M., Vlajkovic, M., Slavkovic, A., Golubovic, E., and Miljkovic, P. (2007) Botulinum toxin type A in combination standard urotherapy for children with dysfunctional voiding. J. Urol. 178(6), 2599-2602.
16. Kajbafzadeh, A.M., Moosavi, S., Tajik, P., Arshadi, H., Payabvash, S., Salmasi, A.H., Akbari, H.R., and Nejat, F. (2006) Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele. Urology 68(5), 1091-1096.
17. Schulte-Baukloh, H., Weiss, C., Stolze, T., Herholz, J., Sturzebecher, B., Miller, K., and Knispel, H.H. (2005) Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction. Eur. Urol. 48(6), 984-990.
18. Maizels et al. (1997) Abstract presented at the American Academy of Pediatrics Annual Meeting.
19. Mokhless, I., Gaafar, S., Fouda, K., Shafik, M., and Assem, A. (2006) Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder. J. Urol. 176(4 Pt 2), 1767-1770.
20. Schulte-Baukloh, H., Bigalke, H., Heine, G., Pape, D., Stuerzebecher, B., Miller, K., and Knispel, H.H. (2007) Antibodies against botulinum neurotoxin type A as a cause of treatment failure after the first detrusor injection. Urology 69(3), 575.e13-575.e15.